<DOC>
	<DOCNO>NCT02339844</DOCNO>
	<brief_summary>The study prospective 2 year multimodal follow-up study initially antipsychotic-naïve first-episode psychotic patient involve standardized intervention monotherapy aripiprazole first 6 week . Patients match healthy control examine 6 week , 6 month 2 year . They examine MR-scannings , neurocognitive test , EEG , PET-scannings .</brief_summary>
	<brief_title>Pan European Collaboration Antipsychotic Naïve Schizophrenia II</brief_title>
	<detailed_description>The study prospective 2 year multimodal follow-up study initially antipsychotic-naïve first-episode psychotic patient involve standardized intervention monotherapy aripiprazole first 6 week . Patients match healthy control examine baseline 6 week , 6 month 2 year . Levels glutamate gamma-aminobutyric acid ( GABA ) measure proton magnetic resonance spectroscopy ( 1H-MRS ) anterior cingulate cortex ACC thalamus . Presynaptic Dopamine level measure Positron Emission Tomography Computed Tomography ( PET/CT ) -scanning use 3,4-dihydroxy-6- [ 18F ] fluoro-L-phenylalanine ( 18F-DOPA ) . Disturbances reward system measure functional magnetic resonance imaging ( fMRI ) . Regional cerebral blood flow activity region measure Pseudo-continuous arterial spin labelling ( pCASL ) . The default mode network , functional structural connectivity associate macro circuit measure rest state fMRI , EEG , diffusion tensor imaging . Structural brain change ( grey white matter ) measure MRI . Cognitive function measure neuropsychological test battery , early information processing event relate EEG electromyography ( EMG ) ( psychophysiological examination ) . Further patient psychopathology rat .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Antipsychotic Agents</mesh_term>
	<mesh_term>Aripiprazole</mesh_term>
	<criteria>Inclusion Criteria Patients : Fulfilling diagnostic criterion schizophrenia schizoaffective disorder accord ICD10 ( International Classification Diseases version 10 ) DSMIV/V ( Diagnostic Statistical Manual version 4 /5 ) Age 1845 year Never treat antipsychotic compound central nervous system ( CNS ) stimulants Legally competent Inclusion criterion control : Matching patient age ( +/ 2 year ) , sex parental socioeconomic status Age 1845 year No psychiatric physical disease Exclusion Criteria patient : Substance abuse daily basis last 3 month patient fulfil criterion ongoing substance abuse due ICD10/DSMIV/V Treatment antidepressant last 30 day Head injury 5 minute unconsciousness Patients involuntarily admit treated Components metal implant operation Pacemaker Pregnancy Severe physical illness Exclusion criterion control First degree relatives psychiatric disease Substance abuse last 3 month positive screening drug urinesample Head injury 5 minute unconsciousness Components metal implant operation Pacemaker Pregnancy Severe physical illness</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>glutamate</keyword>
	<keyword>dopamine</keyword>
	<keyword>cognition</keyword>
	<keyword>cortical thickness</keyword>
	<keyword>ppi</keyword>
	<keyword>p50</keyword>
</DOC>